研究実績

A phase II trial of low-dose nab-paclitaxel for patients with previously treated or recurrent advanced gastric cancer (OGSG1302)

M. Hirota, S. Tamura, H. Taniguchi, A. Takeno, H. Imamura, J. Fujita, J. Matsuyama, Y. Kimura, J. Kawada, M. Hirao, K. Nishikawa, K. Fujitani, Y. Kurokawa, D. Sakai, H. Kawakami, T. Shimokawa, T. Satoh ASCO-GI 2020, San-Francisco, USA,23-25 Jan 2020

前の記事 次の記事 一覧ページへ戻る